| [1] |
Husebye ES, Pearce SH, Krone NP, et al. Adrenal insufficiency[J]. Lancet (London, England)，2021，397(10274)：613-629.
|
| [2] |
中华医学会内分泌学分会肥胖学组. 肾上腺皮质功能减退症患者围手术期糖皮质激素管理专家共识[J]. 中华内分泌代谢杂志，2022，38(1)：1-6.
|
| [3] |
Eaton WW, Rose NR, Kalaydjian A, et al. Epidemiology of autoimmune diseases in Denmark[J]. J Autoimmun，2007，29(1)：1-9.
|
| [4] |
LøVåS K, Husebye ES. High prevalence and increasing incidence of Addison′s disease in western Norway[J]. Clin Endocrinol，2002，56(6)：787-791.
|
| [5] |
Olafsson AS, Sigurjonsdottir HA. Increasing prevalence of Addison disease: results from a nationwide study[J]. Endocr Pract，2016，22(1)：30-35.
|
| [6] |
Laureti S, Vecchi L, Santeusanio F, et al. Is the prevalence of Addison′s disease underestimated？[J]. J Clin Endocrinol Metab，1999，84(5)：1-5.
|
| [7] |
Hong AR, Ryu OH, Kim SY, et al. Characteristics of Korean patients with primary adrenal insufficiency: a registry-based nationwide survey in Korea[J]. Endocrinol Metab (Seoul)，2017，32(4)：466-474.
|
| [8] |
Takayanagi R, Miura K, Nakagawa H, et al. Epidemiologic study of adrenal gland disorders in Japan[J]. Biomed Pharmacother，2000，54 Suppl 1：164s-168s.
|
| [9] |
Calina D, Docea AO, Golokhvast KS, et al. Management of endocrinopathies in pregnancy: a review of current evidence[J]. Int J Environ Res Public Health，2019，16(5)：1-25.
|
| [10] |
Schneiderman M, Czuzoj-Shulman N, Spence AR, et al. Maternal and neonatal outcomes of pregnancies in women with Addison′s disease: a population-based cohort study on 7.7 million births[J]. BJOG，2017，124(11)：1772-1779.
|
| [11] |
Langlois F, Lim DST, Fleseriu M. Update on adrenal insufficiency: diagnosis and management in pregnancy[J]. Curr Opin Endocrinol Diabetes Obes，2017，24(3)：184-192.
|
| [12] |
Woodcock T, Barker P, Daniel S, et al. Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK[J]. Anaesthesia，2020，75(5)：654-663.
|
| [13] |
Carr BR, Parker CR Jr, Madden JD, et al. Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy[J]. Am J Obstet Gynecol，1981，139(4)：416-422.
|
| [14] |
Anand G, Beuschlein F. Management of endocrine disease: fertility, pregnancy and lactation in women with adrenal insufficiency[J]. Eur J Endocrinol，2018，178(2)：R45-53.
|
| [15] |
Frise CJ, Williamson C. Endocrine disease in pregnancy[J]. Clin Med (Lond)，2013，13(2)：176-181.
|
| [16] |
Motosko CC, Bieber AK, Pomeranz MK, et al. Physiologic changes of pregnancy: a review of the literature[J]. Int J Womens Dermatol，2017，3(4)：219-224.
|
| [17] |
Richardson BS, Wakim E, Dasilva O, et al. Preterm histologic chorioamnionitis: impact on cord gas and pH values and neonatal outcome[J]. Am J Obstet Gynecol，2006，195(5)：1357-1365.
|
| [18] |
Manoharan M, Sinha P, Sibtain S. Adrenal disorders in pregnancy, labour and postpartum - an overview[J]. J Obstet Gynaecol，2020，40(6)：749-758.
|
| [19] |
Gjerstad JK, Lightman SL, Spiga F. Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility[J]. Stress，2018，21(5)：403-416.
|
| [20] |
Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline[J]. J Clin Endocrinol Metab，2016，101(2)：364-389.
|
| [21] |
Fleseriu M, Hashim IA, Karavitaki N, et al. Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline[J]. J Clin Endocrinol Metab，2016，101(11)：3888-3921.
|
| [22] |
Yanase T, Tajima T, Katabami T, et al. Diagnosis and treatment of adrenal insufficiency including adrenal crisis: a Japan Endocrine Society clinical practice guideline [Opinion][J]. Endocr J，2016，63(9)：765-784.
|
| [23] |
Suri D, Moran J, Hibbard JU, et al. Assessment of adrenal reserve in pregnancy: defining the normal response to the adrenocorticotropin stimulation test[J]. J Clin Endocrinol Metab，2006，91(10)：3866-3872.
|
| [24] |
Bancos I, Hahner S, Tomlinson J, et al. Diagnosis and management of adrenal insufficiency[J]. Lancet Diabetes Endocrinol，2015，3(3)：216-226.
|
| [25] |
Shrivastava S, Chen B, Dworkin LD, et al. Relapse of Nephrotic Syndrome after adrenocorticotropic hormone-induced remission: implications of adrenocorticotropic hormone antibodies[J]. Am J Nephrol，2020，51(5)：390-394.
|
| [26] |
陈家伦. 临床内分泌学[M]. 上海：上海科学技术出版社，2011：549-554.
|
| [27] |
Schmidt IL, Lahner H, Mann K, et al. Diagnosis of adrenal insufficiency: evaluation of the corticotropin-releasing hormone test and Basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease[J]. J Clin Endocrinol Metab，2003，88(9)：4193-4198.
|
| [28] |
Lebbe M, Arlt W. What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy？[J]. Clin Endocrinol，2013，78(4)：497-502.
|
| [29] |
葛均波，徐永健. 内科学[M]. 9版．北京：人民卫生出版社，2018：713-715.
|
| [30] |
Arlt W, Callies F, Van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency[J]. N Engl J Med，1999，341(14)：1013-1020.
|
| [31] |
Wierman ME, Arlt W, Basson R, et al. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline[J]. J Clin Endocrinol Metab，2014，99(10)：3489-3510.
|
| [32] |
Esteban NV, Loughlin T, Yergey AL, et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry[J]. J Clin Endocrinol Metab，1991，72(1)：39-45.
|
| [33] |
Plat L, Leproult R, L′Hermite-Baleriaux M, et al. Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning[J]. J Clin Endocrinol Metab，1999，84(9)：3082-3092.
|
| [34] |
Isidori AM, Venneri MA, Graziadio C, et al. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial[J]. Lancet Diabetes Endocrinol，2018，6(3)：173-185.
|
| [35] |
Johannsson G, Nilsson AG, Bergthorsdottir R, et al. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation[J]. J Clin Endocrinol Metab，2012，97(2)：473-481.
|
| [36] |
Guarnotta V, Ciresi A, Pillitteri G, et al. Improved insulin sensitivity and secretion in prediabetic patients with adrenal insufficiency on dual-release hydrocortisone treatment: a 36-month retrospective analysis[J]. Clin Endocrinol，2018，88(5)：665-672.
|
| [37] |
Nilsson AG, Bergthorsdottir R, Burman P, et al. Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study[J]. Eur J Endocrinol，2017，176(6)：715-725.
|
| [38] |
Frey KR, Kienitz T, Schulz J, et al. Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency[J]. Endocr Connect，2018，7(6)：811-818.
|
| [39] |
Quinkler M, Ekman B, Marelli C, et al. Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency[J]. Endocr Eonnect，2017，6(1)：1-8.
|
| [40] |
Quinkler M, Hahner S, Johannsson G, et al. Saving lives of patients with adrenal insufficiency: a pan-European initiative？[J]. Clin Endocrinol，2014，80(3)：319-321.
|
| [41] |
Hahner S, Loeffler M, Bleicken B, et al. Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies[J]. Eur J Endocrinol，2010，162(3)：597-602.
|
| [42] |
Lekarev O, New MI. Adrenal disease in pregnancy[J]. Best Pract Res Clin Endocrinol Metab，2011，25(6)：959-973.
|
| [43] |
Ahmed M, Bashir M, Okunoye GO, et al. Adrenal disease and pregnancy: an overview[J]. Obstet Gynaecol，2021，23(4)：265-277.
|
| [44] |
Bothou C, Anand G, Li D, et al. Current management and outcome of pregnancies in women with adrenal insufficiency: experience from a multicenter survey[J]. J Clin Endocrinol Metab，2020，105(8)：e2853-2863.
|
| [45] |
Cheang KI, Sharma ST, Nestler JE. Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome？[J]. Gynecol Endocrinol，2006，22(11)：595-604.
|
| [46] |
Greenberger PA, Odeh YK, Frederiksen MC, et al. Pharmacokinetics of prednisolone transfer to breast milk[J]. Clin Pharmacol Ther，1993，53(3)：324-328.
|
| [47] |
Arlt W, Society for Endocrinology Clinical Committee. Society For Endocrinology Endocrine emergency guidance: emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients[J]. Endocr Connect，2016，5(5)：G1-3.
|